1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Mexico Pharmaceuticals and Healthcare Report Q2 2016

Mexico Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 81 pages

Includes 3 FREE quarterly updates

Headline Expenditure Projections

- Pharmaceuticals: MXN177.3bn (USD11.2bn) in 2015 to MXN182.8bn (USD10.3bn) in 2016; +3.1% inlocal currency terms and -7.6% in US dollar terms.

- Healthcare: MXN1,126.7bn (USD71.0bn) in 2015 to MXN1,194.0bn (USD67.5bn) in 2016; +6.0% inlocal currency terms and -5.0% in US dollar terms.

Table Of Contents

Mexico Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals And Healthcare Forecasts (Mexico 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mexico 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Mexico 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Mexico 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Mexico 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Mexico 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Mexico 2014-2020) 30
Industry Risk Reward Index 31
Americas Risk/Reward Index 31
Mexico Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Advertising 39
Intellectual Property Issues 40
Counterfeit Medicines 42
Pricing Regime 43
Reimbursement Regime 44
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Mexico 2010-2015) 47
Table: Healthcare Personnel (Mexico 2010-2015) 47
Table: Healthcare Activity (Mexico 2010-2015) 48
Table: List Of Hospitals In Mexico With Joint Commission International Accreditation 51
Research And Development 51
Clinical Trials 52
Epidemiology 53
Competitive Landscape 57
Research-Based Industry 57
Click here to enter text 58
Table: Multinational Market Activity 59
Generic Drugmakers 60
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 62
Table: IMSS Financial Indicators, 2000-2011 (MXNmn) 62
Company Profile 64
Boehringer Ingelheim 64
Genomma Labs 67
Demographic Forecast 70
Demographic Outlook 70
Table: Population Headline Indicators (Mexico 1990-2025) 71
Table: Key Population Ratios (Mexico 1990-2025) 71
Table: Urban/Rural Population and Life Expectancy (Mexico 1990-2025) 72
Table: Population By Age Group (Mexico 1990-2025) 72
Table: Population By Age Group % (Mexico 1990-2025) 73
Glossary 75
Methodology 77
Pharmaceutical Expenditure Forecast Model 77
Healthcare Expenditure Forecast Model 77
Notes On Methodology 78
Risk/Reward Index Methodology 79
Index Overview 80
Table: Pharmaceutical Risk/Reward Index Indicators 80
Indicator Weightings 81

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.